GRAIL, Inc.
GRALNASDAQHealthcareDiagnostics & Research
As of Oct 16, 2026 close
- Market cap
- $5.84B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $41.50$166.48
- Volume (live)
- -
- Avg. volume (3M)
- 1.33M
GRAIL (GRAL) Stock Price & Financial Analysis
GRAIL Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $117.06 - $136.50 |
|---|---|
| 52-Week High | $166.48 |
| 52-Week Low | $41.50 |
| Open | $134.02 |
| Volume (last close) | 1.30M |
| Average Volume (3M) | 1.33M |
| Revenue (TTM) | 165.26M |
|---|---|
| Net Income (TTM) | -391.59M |
| Free Cash Flow (TTM) | -296.16M |
| EPS (TTM) | −$9.75 |
| Profit Margin | -236.95% |
| Operating Margin | -338.40% |
| Return on Equity (ROE) | -15.40% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.84B |
|---|---|
| Shares Outstanding | 43.11M |
| Price to Sales (P/S) | 35.34 |
| Price to Book (P/B) | 2.30 |
| EV/EBITDA | -16.22 |
| 50-Day MA | $96.23 |
|---|---|
| 200-Day MA | $75.65 |
| 1-Year Change | +73.67% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
GRAIL at a Glance
As of the Oct 16, 2026 close, GRAIL (GRAL) has a market capitalization of $5.84B. The stock trades at 35.3× sales. Over the trailing twelve months it lost $391.59M on revenue of $165.26M and burned $296.16M of free cash flow. Revenue grew 23.1% year over year.
As of its latest reported balance sheet, it holds $55.65M in cash and securities against $91.31M of debt, a net debt position of $35.66M.
GRAIL does not currently pay a dividend.
The share price is up 73.7% over the past year. At $117.81 (the Oct 16, 2026 close) it sits within its 52-week range of $41.50 to $166.47, above its 200-day moving average of $75.65.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $133.67, 13.5% above the Oct 16, 2026 close.
Frequently Asked Questions About GRAIL
What is the current stock price for GRAL?
As of the Oct 16, 2026 close, GRAL stock trades at $117.81. The 52-week range is $41.50–$166.48, with a day range of $117.06–$136.50.
What is the P/E ratio for GRAL?
The P/E ratio (Price-to-Earnings) for GRAL is shown in the Key Statistics section. This valuation metric helps compare GRAIL, Inc. to industry peers.
Does GRAL pay dividends?
GRAIL does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GRAL?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for GRAL is Buy. The average 12-month price target is $133.67, a 13.5% upside from the Oct 16, 2026 close of $117.81.
What is the market cap of GRAL?
As of the Oct 16, 2026 close, GRAIL's market capitalization is $5.08B, classifying it as a mid-cap company. GRAIL operates in the Healthcare sector within the Diagnostics & Research industry.